These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. Dreger SA; Taylor PM; Allen SP; Yacoub MH J Heart Valve Dis; 2002 Nov; 11(6):875-80; discussion 880. PubMed ID: 12479292 [TBL] [Abstract][Full Text] [Related]
6. Clinical pulmonary autograft valves: pathologic evidence of adaptive remodeling in the aortic site. Rabkin-Aikawa E; Aikawa M; Farber M; Kratz JR; Garcia-Cardena G; Kouchoukos NT; Mitchell MB; Jonas RA; Schoen FJ J Thorac Cardiovasc Surg; 2004 Oct; 128(4):552-61. PubMed ID: 15457156 [TBL] [Abstract][Full Text] [Related]
7. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Rabkin E; Aikawa M; Stone JR; Fukumoto Y; Libby P; Schoen FJ Circulation; 2001 Nov; 104(21):2525-32. PubMed ID: 11714645 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110 [TBL] [Abstract][Full Text] [Related]
9. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. Taylor PM; Allen SP; Dreger SA; Yacoub MH J Heart Valve Dis; 2002 May; 11(3):298-306; discussion 306-7. PubMed ID: 12056719 [TBL] [Abstract][Full Text] [Related]
10. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792 [TBL] [Abstract][Full Text] [Related]
11. Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering. Appleton AJ; Appleton CT; Boughner DR; Rogers KA Tissue Eng Part A; 2009 Dec; 15(12):3889-97. PubMed ID: 19563261 [TBL] [Abstract][Full Text] [Related]
12. Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves. Disatian S; Lacerda C; Orton EC J Heart Valve Dis; 2010 Jan; 19(1):71-8. PubMed ID: 20329492 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. Taylor PM; Allen SP; Yacoub MH J Heart Valve Dis; 2000 Jan; 9(1):150-8. PubMed ID: 10678389 [TBL] [Abstract][Full Text] [Related]
14. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Walker GA; Masters KS; Shah DN; Anseth KS; Leinwand LA Circ Res; 2004 Aug; 95(3):253-60. PubMed ID: 15217906 [TBL] [Abstract][Full Text] [Related]
15. Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease. Han RI; Black A; Culshaw GJ; French AT; Else RW; Corcoran BM Am J Vet Res; 2008 Jun; 69(6):763-9. PubMed ID: 18518656 [TBL] [Abstract][Full Text] [Related]
16. Expression and function of the integrin alpha9beta1 in bovine aortic valve interstitial cells. Wiester LM; Giachelli CM J Heart Valve Dis; 2003 Sep; 12(5):605-16. PubMed ID: 14565714 [TBL] [Abstract][Full Text] [Related]